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A retinoraphe projection regulates serotonergic
activity and looming-evoked defensive behaviour
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Animals promote their survival by avoiding rapidly approaching objects that indicate threats.
In mice, looming-evoked defensive responses are triggered by the superior colliculus (SC)
which receives direct retinal inputs. However, the speciﬁc neural circuits that begin in the
retina and mediate this important behaviour remain unclear. Here we identify a subset of
retinal ganglion cells (RGCs) that controls mouse looming-evoked defensive responses
through axonal collaterals to the dorsal raphe nucleus (DRN) and SC. Looming signals
transmitted by DRN-projecting RGCs activate DRN GABAergic neurons that in turn
inhibit serotoninergic neurons. Moreover, activation of DRN serotoninergic neurons reduces
looming-evoked defensive behaviours. Thus, a dedicated population of RGCs signals rapidly
approaching visual threats and their input to the DRN controls a serotonergic self-gating
mechanism that regulates innate defensive responses. Our study provides new insights into
how the DRN and SC work in concert to extract and translate visual threats into defensive
behavioural responses.
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D
efensive behaviour in response to rapidly approaching
objects is an innate self-defence response remark-
ably conserved across species, including humans1–8.
Simulations of a looming object that mimic an approaching
aerial predator can initiate a rapid escape response and retinal
projections to the midbrain optic tectum or the mammalian
superior colliculus (SC) provide the sensory input that initiates
rapid defence responses9–12. The SC in turn informs the
amygdala where fear responses are assigned to this speciﬁc
sensory experience13,14. The neural circuits beginning in the
retina that regulate looming-evoked defensive behaviour are not
well understood.
The ascending serotonergic system derived from the midbrain
dorsal raphe nucleus (DRN) may inﬂuence the expression of
defensive responses through activation of a diverse set of
serotonin (5-HT) receptor subtypes distributed in fear/
threat-related regions, including the amygdala and prefrontal
cortex15–20. Revealing the structure and function of the precise
circuit related to the DRN is important for the understanding of
how the serotonergic system exerts its inﬂuence upon defensive
responses. The DRN in several species including primates receives
retinal afferents and DRN-projecting retinal ganglion cells
(RGCs) regulate serotonergic signalling in the brain21,22. It is
worth noting that in the Mongolian gerbil DRN-projecting RGCs
also send collateral branches to the SC23. Therefore, if the DRN
received looming-related signals transmitted from RGCs with
branching axons innervating the SC, it might be in a position to
modulate looming-evoked behaviour via its extensive 5-HT
projections.
In this study, by combining conventional neurotracer and
transneuronal rabies virus tracing techniques, we identiﬁed a
retinoraphe projection in the mouse with DRN-projecting RGCs
also sending branching axons to the SC. In the DRN these RGCs
selectively innervate GABA neurons, which in turn modulate
DRN 5-HT neuron activity. The role of DRN/SC-projecting
RGCs in the regulation of looming-evoked defensive responses
was examined using an array of brain circuit interrogation tools,
including immunotoxin-based RGC ablation, c-Fos activity
mapping, ﬁbre photometry, chemogenetics and optogenetics.
We report that DRN/SC-projecting RGCs are necessary for
looming-induced defensive responses and that DRN 5-HT
neuron activity regulates the circuits that control looming-evoked
behaviour.
Results
RGCs innervate the mouse DRN and SC. Retrograde tracing was
conducted to determine if a retinoraphe projection exists in the
mouse. To deliver retrograde tracer into the DRN while avoiding
the retinorecipient SC, an angled approach was used and the
DRN was reached by passing the electrode through the inferior
colliculus (Fig. 1a); each animal (n¼ 8) received a single injection
of 200 nl of cholera toxin B subunit (CTB) conjugated to Alexa
Fluor 488 (CTB-488). Injections centred in the DRN with no
contamination of the SC (Fig. 1b and Supplementary Fig. 1a–e)
labelled approximately 600 RGCs uniformly distributed across
the retina (573±21 RGCs per retina, n¼ 16; Fig. 1c). The results
indicate that retrograde transport of CTB-488 is an effective
technique for labelling DRN-projecting RGCs in the mouse in
contrast to intraocular CTB-488 injections which do not
adequately label the axons of these RGCs in the DRN24.
We next asked whether RGCs in the mouse send axon
collaterals to the DRN and SC, similar to those in the gerbil23.
Using CTB tracer injections into the DRN (CTB-488) and
SC (CTB-594) to retrogradely label RGCs (n¼ 4 animals)
(Supplementary Fig. 2a), we observed that approximately 90%
of CTB-488-labelled DRN-projecting RGCs were double-labelled
(581 of 652 cells analysed), indicating that individual RGCs in the
mouse send branching axons to the DRN and SC (Supplementary
Fig. 2b–e).
In an attempt to classify DRN-projecting RGCs we used
three well-known markers of RGCs: melanopsin, cocaine and
amphetamine-regulated transcript (CART), and SMI-32. No
CTB-labelled DRN-projecting RGCs were immunopositive for
melanopsin, CART or SMI-32 (Supplementary Fig. 2f–n). Next
we sought to classify DRN-projecting RGCs based on their
pattern of dendritic arborization. CTB-labelled DRN-projecting
RGCs in retinal whole mounts maintained in vitro were
randomly selected and targeted for neurobiotin intracellular
ﬁlling (Fig. 1d). DRN-projecting RGCs have a medium-sized
round soma (diameter¼ 17.3±2.6 mm; n¼ 472 from 6 retinas)
with 3–5 primary dendrites that were generally thick and smooth
(Fig. 1d–g and Supplementary Fig. 3a–f). The dendritic ﬁeld of
DRN-projecting RGCs covers approximately 0.043±0.004mm2
and is asymmetrical; the average dendritic ﬁeld size and soma
diameter did not vary signiﬁcantly with retinal eccentricity
(Supplementary Fig. 3g,h). In z-stack reconstructions of ﬁlled
DRN-projecting RGCs, dendritic processes ramiﬁed in both
sublamina a and b of the inner plexiform layer (Supplementary
Fig. 3a–f).
DRN-projecting RGCs selectively innervate DRN GABA neurons.
To exclude the possibility that DRN CTB injections inadvertently
labelled RGC ﬁbres passing through rather than synapsing in the
DRN25, and further to determine if DRN-projecting RGCs
speciﬁcally target one or both of the two major DRN cell types
(5-HT and GABA), a three-virus tracing technique was used in
combination with Cre-loxP gene-expression26. The modiﬁed
rabies virus SAD-DG-DsRed (EnvA) was pseudotyped with the
avian sarcoma leucosis virus envelope protein (EnvA), limiting
the rabies virus to infect only those neurons that express
TVA, a cognate receptor of EnvA. Additionally, the rabies
glycoprotein (RG) gene required for transneuronal spread beyond
the initially infected neurons (starter cells) was replaced with the
coding sequence of a red ﬂuorescent protein, DsRed (Fig. 2a).
Two Cre-dependent AAV helper virus recombinants,
AAV-DIO-EGFP-TVA and AAV-DIO-RVG, were infused into
the DRN of two strains of mice expressing Cre-recombinase
under the transcriptional control of: (1) the serotonin transporter
promotor (Sert-Cre mice); or (2) the vesicular GABA transporter
promotor (vGAT-Cre mice) to selectively infect DRN 5-HT or
GABA neurons. After allowing 3 weeks for the expression of
EGFP-TVA and RG in the DRN, the rabies virus DRG-DsRed
(EnvA) was injected into the same area (Fig. 2b). One week later
retinas and brains were examined for neurons labelled by the
rabies virus.
The expression of Cre-dependent TVA-EGFP in the DRN was
conﬁrmed to be highly speciﬁc: 96.4% of TVA-EGFP labelled cells
were tryptophan hydroxylase (TPH)-immunopositive in Sert-Cre
animals (648 of 672 cells analysed) and 97.7% of TVA-EGFP
labelled cells in the DRN were non-TPH-immunopositive cells in
vGAT-Cre animals (545 of 558 cells analysed) (Fig. 2c,d). Starter
cells were co-labelled with TVA-EGFP and SAD-DG-DsRed
(EnvA) and were restricted to the DRN (Fig. 2c,d and
Supplementary Fig. 4a). In Sert-Cre animals there were numerous
rabies virus labelled (DsRed-positive) neurons in the DRN which
did not express TVA-EGFP, indicating that these cells were
retrogradely labelled from DRN 5-HT starter cells and are
therefore local inputs; the fact that DRN GABA interneurons
innervate 5-HT neurons is well-documented27 (Fig. 2c,d). As
described previously, we conﬁrmed that DRN 5-HT and GABA
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neurons receive direct innervation from dozens of brain areas,
including the central amygdala and habenula (Supplementary
Fig. 4b)27–29. Labelled RGCs were restricted almost without
exception to the retinas of vGAT-Cre mice: 118 labelled RGCs in
eight vGAT-Cre mouse retinas compared to only two labelled
RGCs in 16 Sert-Cre mouse retinas (Fig. 2e). The dendritic
morphology and distribution pattern of labelled RGCs in
vGAT-Cre mice matched that of CTB-labelled DRN-projecting
RGCs ﬁlled with neurobiotin (Fig. 2f,g and Supplementary
Fig. 4c). The results from these selective rabies virus
transneuronal tracing experiments provide direct evidence that
RGCs synapse on DRN GABA neurons.
Looming-evoked response requires DRN-projecting RGCs.
RGCs that respond to looming visual stimuli send signals to the
SC to initiate defensive responses. Since DRN-projecting RGCs
also innervate the SC, we asked whether these RGCs play a role in
mediating responses to looming stimuli. Using extracellular
recording in retinal whole mounts maintained in vitro,
we examined responses of DRN-projecting RGCs to a looming
stimulus (a dark disk on a grey background that rapidly expanded
from 2 visual angle to 20 visual angle in 250ms (ref. 7)). All
of the recorded CTB-labelled DRN-projecting RGCs (n¼ 11)
showed a transient increase in their ﬁring rate at the onset of the
looming stimulus (Fig. 3a). Some RGCs (n¼ 4) were ﬁlled with
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Figure 1 | Retinal ganglion cells (RGCs) innervate the mouse DRN. (a) Angled trajectory used to eject cholera toxin B subunit Alexa Fluor 488
(CTB-488) into the dorsal raphe nucleus (DRN) while avoiding the superior colliculus (SC). (b) Image of a CTB-488 injection site in the DRN. Note
absence of CTB-488 in the SC; yellow lines demarcate borders of the DRN. (c) Left: retinal whole mount illustrating retrogradely labelled DRN-projecting
RGCs. Retina orientation: S¼ superior, I¼ inferior, N¼ nasal and T¼ temporal. Right: region deﬁned in white box viewed under higher magniﬁcation.
(d) Left: intracellularly ﬁlled DRN-projecting RGCs in a retinal whole mount. Right: region deﬁned in white box viewed under higher magniﬁcation.
(e–g) Intracellularly ﬁlled DRN-projecting RGCs located at different retinal eccentricities relative to optic disc (OD). Arrowheads point to axons. Numbers in
the upper right corner indicate distance between soma and optic disc. Scale bars: (b,c-left) 500mm; (c-right, d-right and e) 50mm; (d-left) 100 mm.
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neurobiotin conﬁrming that their dendritic morphology was
consistent with previously ﬁlled DRN-projecting RGCs (Fig. 3a).
We next wanted to test whether these RGCs are required for
looming-evoked behavioural responses. First we conﬁrmed
that mouse DRN-projecting RGCs labelled with CTB could be
selectively ablated by intraocular injection of the ribosomal toxin
saporin (SAP) conjugated to an antibody generated against CTB
(anti-CTB-SAP) as we reported previously in the gerbil21. This
tool is effective because CTB retrogradely transported to the RGC
soma is delivered to the cell surface via transcytosis30, providing
anti-CTB-SAP access to CTB31. Once bound, the immunotoxin
is internalized to exert its effect as depicted in Fig. 3b. In
retinas treated with anti-CTB-SAP the number of CTB-labelled
DRN-projecting RGCs was reduced approximately 90%
compared to vehicle-injected animals (VEH 562.74±20.0, n¼ 9
versus anti-CTB-SAP 68.2±16.6, n¼ 8; Po0.0001) (Fig. 3c–e).
These results provide the basis for functional studies examining
the role of DRN-projecting RGCs in looming-evoked behaviour.
To determine if DRN-projecting RGCs are required for
looming-evoked escape responses, we used a behavioural assay
of a rapidly expanding dark disk stimulus similar to that used for
the in vitro experiment (looming stimulus  2 of visual angle
expanded to 20 in 250ms) presented overhead 15 times over
10.75 s to evoke an escape response in which mice ﬂee-to-shelter7
(Fig. 3f). The DRN of all animals in these experiments was
injected with CTB and all animals also received intraocular
injections of: (1) phosphate-buffered saline (PBS) (VEH, n¼ 27);
(2) the immunotoxin, anti-CTB-SAP (CTB-SAP, n¼ 10); or
(3) the immunotoxin, anti-melanopsin conjugated to saporin21
(anti-Mel-SAP, n¼ 8).
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Figure 2 | DRN-projecting RGCs selectively innervate DRN GABA neurons. (a) Design of AAV-DIO-RVG, AAV-DIO-EGFP-TVA and SAD-DG-DsRed
(EnvA). (b) Experimental design of virus tracing in Sert-Cre and vGAT-Cre mice. (c) Left, Sert-Cre mouse DRN showing the location of starter cells (white).
Right, a DRN section viewed under higher magniﬁcation showing from left to right: green for TVA-EGFP; blue for anti-TPH immunostaining; magenta for
rabies-DsRed; and merged image showing triple-labelled cells. (d) Left, vGAT-Cre mouse DRN showing the location of starter cells (white). Right, a DRN
section viewed under higher magniﬁcation showing from left to right: green for TVA-EGFP; blue for anti-TPH immunostaining; magenta for rabies-DsRed
and merged image. (e) DRN-projecting RGCs in a retinal whole mount labelled with rabies virus in a vGAT-Cre mouse. (f) Dendritic morphology of a
DRN-projecting RGC ﬁlled with neurobiotin in a wild-type mouse (left) and a DRN-projecting RGC retrogradely labelled by rabies virus in a vGAT-Cre
mouse (right). Note that both cells have asymmetric dendritic ﬁelds and bistratiﬁed dendritic arbors. a,b: sublaminas a and b of the inner plexiform layer
(IPL). (g) Comparison of soma and dendritic ﬁeld diameters between DRN-projecting RGCs ﬁlled with neurobiotin or labelled by rabies virus. ns¼ no
signiﬁcant difference; Scale bars: (c)-left 100 mm; (c)-right 20mm; (e,f) 50mm. Data presented as mean±s.e.m.
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In response to the looming stimulus, a rapid escape to the
shelter was observed in490% of the VEH animals (25 of 27)
(Fig. 3g and Supplementary Movie 1). Two animals froze for a
prolonged period in response to the looming stimulus and these
animals were not included in the kinetic analysis (Fig. 3h).
The looming stimulus did not evoke escape responses in the
anti-CTB-SAP-treated animals; these mice continued to explore
the arena during and after the looming stimulus (Fig. 3g,h and
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RGCs in vehicle (VEH) and anti-CTB-SAP (CTB-SAP)-treated animals. (n¼8 retinas per group), one-way ANOVA; ***Po0.0001. (f) Schematic of
looming animation and testing arena. (g) Representative traces of animal movement during looming stimulation (10.75 s) in VEH and anti-CTB-SAP groups;
time in corner is duration of trace from start to end. (h) Duration from start to end points, peak speed during and after looming stimulation in VEH and
anti-CTB-SAP (CTB-SAP)-treated animals. One-way ANOVA; ***Po0.0001; ns¼ no signiﬁcant difference. (i) The optomotor response of animals treated
with VEH or anti-CTB-SAP (CTB-SAP) tested under photopic and scotopic conditions; the responses in both animal groups under both conditions were
similar. Scale bars: (a,c) 50mm; (d) 1mm. Data presented as mean±s.e.m.
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Supplementary Movie 1). Based on the anatomical analyses
described above, intraocular injection of anti-CTB-SAP would
have killed approximately 90% of the CTB-labelled
DRN-projecting RGCs in these animals. It should be noted that
anti-Mel-SAP animals in which melanopsin-expressing RGCs
were selectively ablated demonstrated escape responses to the
looming stimulus similar to VEH controls (VEH 0.94±0.02 s
versus anti-Mel-SAP 0.91±0.03 s, n¼ 8 animals per group;
P40.05) (Supplementary Fig. 5). These data indicate that
DRN-projecting RGCs are required for looming-evoked escape
responses. In the optomotor test there was no signiﬁcant
difference between VEH and anti-CTB-SAP animals (Fig. 3i),
indicating that RGCs mediating this behaviour were unaffected
by anti-CTB-SAP treatment and that DRN-projecting RGCs are
not required for this behavioural response.
Looming activation of SC-LP-BLA needs DRN-projecting RGCs.
A subcortical circuit from SC-lateral posterior nucleus of
the thalamus-basolateral amygdala (SC-LP-BLA) has been
implicated in the regulation of looming-induced freezing in mice,
the prominent behaviour observed when looming visual stimuli
are presented in an arena that has no shelter14. RGCs
transmitting looming signals to this circuit cannot be identiﬁed
using traditional retrograde tracing methods.
To determine whether there is a di-synaptic circuit linking
DRN-projecting RGCs to LP, we used a modiﬁed rabies
transsynaptic tracing method32. SC neurons were infected by
AAV expressing the RG and histone-Tagged green ﬂuorescent
protein (Helper) (Fig. 4a,b). Next, we injected SAD-DG-DsRed
(EnvA) into LP to infect helperþ LP-projecting SC neurons via
their presynaptic terminals (Fig. 4c). The double infected rabies-
DsRedþ /Glyco-GFPþ SC relay neurons produce infectious
DG-rabies-DsRed that propagates transneuronally to infect the
RGCs that form synapses with them (Fig. 4c). Double infected
neurons were mainly present in the intermediate layer of SC
(n¼ 6 animals) (Fig. 4c). Finally, CTB-488 was injected into
DRN to determine whether DRN-projecting RGCs could provide
di-synaptic input to LP (Fig. 4b). Some of DsRedþ RGCs
with morphological features of DRN-projecting RGCs were
retrogradely labelled by CTB-488 (n¼ 127 cells in 6 animals)
(Fig. 4c). This result suggests that DRN-projecting RGCs provide
di-synaptic input to LP after synapsing in SC.
To determine whether DRN-projecting RGCs regulate the
functional activation of the SC-LP-BLA pathway, a looming-
related c-Fos mapping strategy was adopted to assess changes of
neuronal activity in the SC-LP-BLA pathway. All animals
received DRN CTB injections. Three days later animals
received bilateral intraocular injections of 0.1M PBS (n¼ 16) or
anti-CTB-SAP (n¼ 8). Two weeks later all animals were given 3
days of adaptation in the shelterless arena. On the fourth day,
a single looming stimulus (15 presentations over 10.75 s) was
presented to seven PBS-injected animals (VEH-L) and to the
anti-CTB-SAP-treated animals (SAP-L). Under this paradigm
VEH-L animals responded by ﬂeeing from the centre of the
arena and freezing (Supplementary Movie 2). The remaining
PBS-injected animals (n¼ 9) were treated in a similar manner
with the exception of the presentation of the looming stimulus
(VEH-NL). Looming stimulation signiﬁcantly increased the
number of c-Fos positive neurons in the SC-LP-BLA pathway
in VEH-L compared to VEH-NL animals (Fig. 4d–i). The freezing
response to the looming stimulus was markedly reduced in
SAP-L animals in which DRN-projecting RGCs were ablated
(Supplementary Movie 2) and c-Fos induction was signiﬁcantly
reduced (Fig. 4d–i).
In contrast, there was no signiﬁcant change in the number of
c-Fos positive neurons in dorsal periaqueductal grey (dPAG),
which is considered to play a pivotal role in the regulation
of defensive behaviour (Fig. 4j,k). These results suggest that
DRN-projecting RGCs are part of the SC-LP-BLA circuit that
generates the looming-evoked fear response.
GABA cells activated by looming require DRN-projecting RGCs.
To this point we have established that DRN-projecting RGCs
innervate DRN GABA neurons and are required for looming-
evoked behaviour. To investigate the response of DRN 5-HT and
GABA neurons to looming stimuli, ﬁbre photometry was used to
measure Ca2þ signals in vivo as a surrogate of neuronal spiking
(Fig. 5a). We ﬁrst conﬁrmed the speciﬁcity of the calcium
indicator by injecting AAV-DIO-GCaMP6 into the DRN of
Sert-Cre or vGAT-Cre mice and examining expression:498% of
GCaMP6 expression was observed in DRN neurons expressing
TPH or GABA in Sert-Cre or vGAT-Cre mice, respectively
(Fig. 5b). In freely moving mice, Ca2þ signals were recorded
from DRN 5-HT or GABA neurons during the presentation of
the looming stimulus in an arena without or with a shelter.
Each animal was subjected to ﬁve looming stimulation trials
(10.75 s each) during a 1-h session. In a test arena without a
shelter the looming stimulus reliably evoked freezing behaviour
accompanied by a decrease in Ca2þ signals from 5-HT neurons
in Sert-Cre animals (Fig. 5c and Supplementary Fig. 6a,c) and an
increase in Ca2þ signals from GABA neurons in vGAT-Cre
animals (Fig. 5d and Supplementary Fig. 6b,d). These results
support the viral tracing experiments suggesting that RGCs
transmitting looming signals directly activate DRN GABA
interneurons, which inhibit DRN 5-HT neurons (Supplementary
Fig. 7). Next, we recorded Ca2þ signals from 5-HT neurons
when the looming test was conducted in an arena containing a
shelter. Under this testing condition Ca2þ signals decreased at
the beginning of looming stimulation when mice ﬂed to the
shelter and subsequently increased dramatically beginning about
4 s later while mice were hiding beneath the shelter (Fig. 5c and
Supplementary Fig. 6a). Looming stimulation again produced
the opposite responses in GABA neurons, initially signiﬁcantly
increasing Ca2þ signals followed by a decrease (Fig. 5d and
Supplementary Fig. 6b). These data suggest that once in the safety
of the shelter DRN 5-HT neurons are released from GABA
inhibition evoked by the looming stimulus. Anti-CTB-SAP
treatment eliminated the effects of looming stimulation on
Ca2þ signals of DRN 5-HT and GABA neurons (Fig. 5e,f and
Supplementary Fig. 6a–d). These data support the interpretation
that DRN-projecting RGCs are required for looming-evoked
behaviour mediated by modulation of DRN 5-HT and GABA
neuron activity.
DRN 5-HT system inhibits looming-evoked defensive responses.
The results provided above suggest that looming stimulation
inhibits the activity of DRN 5-HT neurons. We therefore
reasoned that activation of DRN 5-HT neurons might attenuate
looming-evoked behaviour. To test this hypothesis directly, we
ﬁrst performed long-term speciﬁc chemogenetic activation of
DRN 5-HT neurons using a Cre-dependent virus encoding the
neuronal activator DREADD hM3D (ref. 33). AAV-DIO-hM3D-
mCherry was infused into the DRN of Sert-Cre mice (Fig. 6a).
Two weeks later, 5-HT neurons were chemogenetically activated
via intraperitoneal (i.p.) injection of clozapine N-oxide (CNO) as
conﬁrmed by double labelling for mCherry and c-Fos (Fig. 6a).
Next, looming-evoked defensive behaviour in an arena with or
without a shelter was examined in AAV-DIO-hM3D-mCherry
injected Sert-Cre mice injected with saline (hM3D-Saline, n¼ 6)
or CNO (hM3D-CNO, n¼ 7) 30min before behavioural testing.
Looming-evoked defensive responses were blocked in animals
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with DRN 5-HT neurons chemogenetically activated
(duration from start to end (s): hM3D-Saline, 0.95±0.21
versus hM3D-CNO, 10.75±0, Po0.0001; peak speed during
looming stimulation (cm s 1): hM3D-Saline, 199.25±13.25
versus hM3D-CNO, 91.85±13.26, Po0.0001) (Fig. 6c,d and
Supplementary Movie 3). Control Sert-Cre animals (n¼ 6)
transfected with AAV-DIO-mCherry and given CNO i.p.
responded to the looming stimulus in a manner similar to
hM3D-Saline-treated animals demonstrating that CNO itself was
not responsible for the inhibition of looming-evoked responses
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observed in the hM3D-CNO animals (Fig. 6c,d). Next, short-term
optogenetic activation of DRN 5-HT neurons during looming
stimulation using a Cre-dependent virus encoding channlerho-
dopsin-2 (ChR2) was performed (Supplementary Fig. 8a–c).
Optogenetic activation of DRN 5-HT neurons during looming
stimulation also impaired looming-evoked defensive responses
(Supplementary Fig. 8d,e and Supplementary Movie 4). Together
these results suggest that selective activation of DRN 5-HT
neurons inhibits looming-evoked defensive responses.
Since data from in vivo ﬁbre photometry recording and in vitro
brain slice recording suggest that looming signals transmitted by
DRN-projecting RGCs inhibit DRN 5-HT neurons through direct
activation of DRN GABA neurons (Fig. 5 and Supplementary
Fig. 7). We next asked whether inhibition of DRN GABA neurons
could also impair looming-evoked defensive responses. To
address this question, we ﬁrst performed long-term chemogenetic
inhibition of DRN GABA neurons using a Cre-dependent
virus encoding the inactivating DREADD hM4D (ref. 34).
AAV-DIO-hM4D-mCherry was infused into the DRN of
vGAT-Cre mice (Fig. 6b). Two weeks later, DRN GABA neurons
were chemogenetically inhibited via i.p. injection of CNO as
conﬁrmed by double labelling for mCherry and c-Fos (Fig. 6b).
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Sert-Cre mice. Middle panels: representative images of the DRN illustrating c-Fos in neurons expressing hM3D-mCherry; Right: percentage of total
hM3Dþ cells expressing c-Fos was signiﬁcantly increased in animals (n¼ 5) 30min after CNO administration compared to saline (one-way ANOVA,
***Po0.0001). (b) Left: AAV-DIO-hM4D-mCherry was injected into DRN of vGAT-Cre mice. Middle panels: Representative images of the DRN illustrating
c-Fos in neurons expressing hM4D-mCherry Right: percentage of total hM4Dþ cells expressing c-Fos was signiﬁcantly decreased in animals (n¼ 5)
30min after CNO administration compared to saline. One-way ANOVA, ***Po0.0001. (c) Representative traces of animal movement during looming
stimulation (10.75 s) in CNO-treated controls (mCherry-CNO), saline-treated controls (hM3D-Saline and hM4D-Saline), chemogenetic activation of DRN
5-HT neurons (hM3D-CNO) and chemogenetic inhibition of DRN GABA neurons (hM4D-CNO). (d) Duration from start to end points, peak speed during
and after looming stimulation in mCherry-CNO, hM3D-Saline and hM3D-CNO-treated Sert-Cre animals (orange), and mCherry-CNO, hM4D-Saline, and
hM4D-CNO-treated vGAT-Cre animals (green). One-way ANOVA; **Po0.001; ***Po0.0001; ns¼ no signiﬁcant difference. Scale bars: (a,b)-left 100mm;
(a,b)-right 20mm. Data presented as mean±s.e.m.
Figure 5 | DRN GABA and 5-HT neuron Ca2þ signals recorded via ﬁbre photometry during looming stimulation. (a) Schematic of ﬁbre photometry rig
used to measure looming-evoked Ca2þ signals in freely behaving mice. AAV-DIO-GCaMP6m was injected into DRN of vGAT-Cre or Sert-Cre mice and
subsequently a 230mm ﬁbre optic implant was implanted in the DRN. (b) Representative images of DRN from a Sert-Cre and a vGAT-Cre mouse 2 weeks
after AAV-DIO-GCaMP6m injection. (c) Top: heat maps (ﬁve trials) illustrating looming-evoked Ca2þ signals of DRN 5-HTneurons from a representative
VEH-treated Sert-Cre mouse; Middle: averaged response of the ﬁve trials; Bottom: averaged response of the entire test group (n¼ 25 trials from 5 animals)
tested in an arena with/without a shelter. Blue segments indicate statistically signiﬁcant decrease from the baseline (Po0.05; permutation test).
(d) Top: heat maps (ﬁve trials) illustrating looming-evoked Ca2þ signals of DRN GABA neurons from a representative VEH-treated vGAT-Cre mouse;
Middle: averaged response of the ﬁve trials; Bottom: Averaged response of the entire test group (n¼ 25 trials from 5 animals) tested in an arena
with/without a shelter. Red segments indicate statistically signiﬁcant increase from the baseline (Po0.05; permutation test). (e) Top: Heat maps
(ﬁve trials) illustrating looming-evoked Ca2þ signals of DRN 5-HTneurons from a representative Anti-CTB-SAP-treated Sert-Cre mouse; Middle: Averaged
response of the ﬁve trials; Bottom: Averaged response of the entire test group (n¼ 25 trials from 5 animals) tested in an arena with/without shelter.
(f) Top: Heat maps (ﬁve trials) illustrating looming-evoked Ca2þ signals of DRN GABA neurons from a representative Anti-CTB-SAP-treated vGAT-Cre
mouse; Middle: Averaged response of the ﬁve trials; Bottom: Averaged response of the entire test group (n¼ 25 trials from 5 animals) tested in an arena
with/without shelter. Scale bars: (b)-left 100 mm; (b)-right 20mm.
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Next, looming-evoked defensive behaviour in an arena with a
shelter was examined in vGAT-Cre mice injected with
AAV-DIO-hM4D-mCherry 30min after i.p. injection of saline
(hM4D-Saline, n¼ 5) or CNO (hM4D-CNO, n¼ 8). Although
looming stimulation continued to evoke escape behaviour in
hM4D-CNO-treated animals, inhibition of DRN GABA neurons
signiﬁcantly slowed the response (duration start to end (s):
hM4D-Saline, 1.01±0.26 versus hM4D-CNO, 5.06±1.32,
Po0.0001; peak speed during looming stimulation (cm s 1):
hM4D-Saline, 183.36±10.53 versus hM4D-CNO, 147.12±14.52,
Po0.001) (Fig. 6c,d and Supplementary Movie 5). hM4D-Saline-
treated and hM4D-CNO-treated animals were re-tested a week
later with a single looming stimulus (0.25 s). The control mice
immediately ﬂed to the shelter whereas the CNO-treated animals
did not respond to the stimulus (Supplementary Movie 6).
Thus using a single trial paradigm CNO-evoked inhibition of
DRN GABA neurons blocked the looming response. Control
vGAT-Cre animals (n¼ 6) transfected with mCherry-CNO
demonstrated rapid looming-evoked responses similar to
hM4D-Saline animals (Fig. 6c,d). Next, short-term optogenetic
inhibition of DRN GABA neurons during looming stimulation
using Cre-dependent virus encoding enhanced halorhodopsin
3.0 (eNpHR3.0) were performed (Supplementary Fig. 8f–h).
Optogenetic inhibition of DRN GABA neurons during looming
stimulation also impaired looming-evoked defensive responses
(Supplementary Fig. 8i,j and Supplementary Movie 7). Thus
normal retinally induced activity of DRN GABA neurons is
required for the rapid looming-evoked escape response.
In summary, a bistratiﬁed RGC type was identiﬁed that
innervates the DRN and SC via branching axons. Looming signals
transmitted by these RGCs result in the activation of the
SC-LP-BLA pathway and the indirect inhibition of the DRN
serotonergic system via direct activation of DRN GABA
interneurons. Inhibition of DRN 5-HT neurons appears to be
required to facilitate looming-evoked defensive responses.
Discussion
The ability to detect and respond to rapidly approaching objects
is an innate defensive behaviour fundamental to survival and
conserved across species. In mice, it is believed that retinal
projections to the SC mediate looming-evoked escape and
freezing responses12–14. However, because more than 90% of
the 30 different identiﬁed types of mouse RGC innervate the SC,
it has not been possible to use standard retrograde tracers to
identify the RGCs that transmit looming-evoked signals
centrally35,36. In this work, we identiﬁed a dedicated circuitry
from the retina to the SC and DRN that regulates looming-evoked
responses. We began by demonstrating DRN-projecting RGCs in
the mouse. This was necessary because it has been reported that
unlike other rodents, RGCs did not innervate the mouse DRN.
However, the absence of labelled retinal ﬁbres in the mouse
DRN was based on anterograde CTB tracing24 and as recently
suggested, this technique underrepresents the retinoraphe
projection37, perhaps due to reduced access of the large CTB
molecule at RGC branch points38. Here, we demonstrate that
RGCs innervate the mouse DRN using retrograde tracing with
CTB and importantly, with a modiﬁed rabies virus that restricted
infection to genetically targeted DRN neurons26. We also tested
whether DRN/SC-projecting RGCs were capable of responding to
a looming stimulus. Extracellular recordings in vitro provided
initial evidence that these RGCs could indeed respond to a
simulation of a rapidly approaching object. However, additional
studies are needed to fully characterize these RGCs including a
description of their synaptic inputs.
Using the modiﬁed rabies virus retrograde tracing technique
we additionally found that DRN-projecting RGCs selectively
innervate GABA neurons. It is well documented that DRN GABA
neurons play a pivotal role in the modulation of serotonergic
output through direct synaptic connections with DRN 5-HT
neurons39–41. Thus, it seemed reasonable to postulate that
activation of the direct retinoraphe pathway would decrease the
activity of serotonergic neurons in the DRN. This prediction was
borne out by our experiments using ﬁbre photometry to record
Ca2þ signals from genetically identiﬁed DRN 5-HT and GABA
neurons in mice during looming stimulation: DRN GABA
neurons were activated while the activity of DRN 5-HT
neurons was reduced when animals were tested in an arena
which contained no shelter. Similar experiments performed in an
arena with a shelter were even more informative. In these
experiments the looming stimulus reliably induced mice to
rapidly ﬂee into the shelter and then freeze for a short period
(Supplementary Movie 1). Associated with this behaviour,
the Ca2þ signals from 5-HT neurons initially decreased at the
beginning of looming stimulation when animals ﬂed into the
shelter but then increased a few seconds later when the mouse
was safely hidden; DRN GABA neurons responded in an opposite
manner. We interpret these data based on our previous ﬁnding
that aversive stimuli activate DRN GABA neurons, but not 5-HT
neurons42,43. The sense of safety or relief realized after avoiding
the threatening stimulus is apparently reﬂected by activation of
DRN 5-HT neurons while DRN GABA neurons are inactivated.
In support of these interpretations, looming-stimuli failed to
evoke defensive behaviour and had no effect on DRN neuronal
activity after selective immunotoxin ablation of DRN-projecting
RGCs.
The dual role of 5-HT in the regulation of innate and learned
fear responses has long been recognized44. Our experiments
demonstrated that activation of DRN 5-HT neurons impaired
looming-evoked defensive responses. This is consistent with
previous ﬁndings that 5-HT can play an inhibitory role in the
modulation of innate fear responses20,45,46. Furthermore, we
found that inhibition of DRN GABA neurons signiﬁcantly
retarded the response to the overhead threat. Combined with
the in vitro recording data that provide direct evidence that
activation of DRN GABA neurons inhibits 5-HT neurons,
it appears that looming-induced indirect inhibition of DRN
5-HT neurons is required for the facilitation of looming-evoked
defensive responses.
Escape responses to a rapidly approaching overhead predator
or to an object on a collision course must be correspondingly
rapid and therefore the number of synaptic integrations in the
escape circuitry is under temporal constraint. In the current
paradigm simulating a rapidly approaching overhead threat,
escape responses can be initiated with a latency of less than
250ms after stimulus onset7. However, despite their short
latencies, escape responses in animals and humans are made
based on an assessment of risk or threat and therefore can be
modulated in the short term and in the long term these responses
can be modiﬁed by learning and memory47–49. In the circuitry we
describe in the current report, the temporal delays built in by the
requirement of the looming stimulus to disinhibit DRN 5-HT
neurons must be offset by some advantage. The advantage of the
additional synaptic delay may be the plasticity afforded in this
circuitry and the widespread projections of the DRN 5-HT
neurons. Excitatory inputs directly onto DRN 5-HT neurons
from cortical and subcortical sites could play a role in modulating
RGC activation of DRN GABA neurons50.
The looming-evoked visual circuitry we describe expands the
role of the DRN in sensory processing by showing that the
primary sensory input regulates itself via the DRN. Looming-
evoked retinal signals to the DRN are essential to disengage a
serotonergic gating mechanism that permits the salient signal to
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be processed by the looming circuits to initiate defensive
responses. In humans, anxiety or fear might involve a reactivation
of innate fear circuits51. The inhibitory role of DRN 5-HT
neurons in the regulation of looming induced defensive responses
may provide an important new mechanism for the usage of
selective serotonin reuptake inhibitors in treating fear-related
disorders, such as phobia.
Methods
Animals. All experiments were approved by Jinan University Institutional Animal
Care and Use Committee. Adult male (6–8 weeks) C57BL/6, Sert-Cre mice (strain
name B6.Cg-Tg(Slc6a4-Cre)ET33Gsat; MMRRC, Davis, CA, USA) and vGAT-Cre
mice (strain name B6.FVB-Tg(Slc32a1-cre) 2.1Hzo/FrkJ; Jackson Laboratory, Ben
Harbor, ME, USA) were used in this study. Animals were housed in a 12 h:12 h
light–dark cycle (lights on at 7:00) with food and water provided ad libitum.
Animals were randomly allocated to experimental and control groups.
Experimenters were blind to experimental group and order of testing was
counterbalanced during behavioural experiments.
Surgery and intracranial injection. Mice were anesthetized (Avertin, 13 ml g 1,
i.p.) and placed in a stereotaxic instrument (RWD, Shenzhen, China).
Erythromycin eye ointment was applied to prevent corneal drying and a heat pad
(RWD, Shenzhen, China) was used to hold body temperature at 37 C. A small
craniotomy hole was made using a dental drill (OmniDrill35, WPI) and a
micropipette connected to a Quintessential Stereotaxic Injector (Stoelting, Wood
Dale, IL, USA) and its controller (Micro4; WPI, Sarasota, USA) was used for
injection.
CTB Alexa Fluor conjugates (CTB-488, C-3,477; CTB-594, C-34,777; CTB-647,
C-34,778; Invitrogen Inc., Grand Island, NY, USA) was injected into the DRN
(0.2ml per injection, CTB-488 or CTB-647; AP:  5.2mm; ML: ±0mm;
DV:  2.7mm, with a 15 angle); intermediate layers of SC (0.4 ml per injection,
CTB-594; AP:  3.7mm; ML: ±0.6mm; DV:  1.85mm), followed by 0.03 ml oil
(sesame oil; Sigma-Aldrich Corp.) to limit the diffusion of CTB tracer.
For cell-type-speciﬁc tracing, a total volume of 0.8 ml containing an equal
volume of AAV-EF1a-DIO-EGFP-TVA (2 1012 particles per ml) and
AAV-EF1a-DIO-RVG (2 1012 particles per ml) was injected at the DRN
(eight Sert-Cre mice and eight vGAT-Cre mice) (coordinates: AP:  5.2mm;
ML: ±0mm; DV:  2.7mm, with a 15 angle). The pipette was held in place
for 10min, and then withdrawn slowly. Twenty-one days later, 0.4 ml of
SAD-DG-DsRed (EnvA) (2 108 particles per ml) was injected into the same site.
For di-synaptic tracing retina-SC-LP pathway, 0.8 ml helper virus
(rAAV-hSyn-GFP-2a-TVA-2a-RVG-WPRE-pA) (2 108 particles per ml) was
injected into the SC (six C57BL/6 mice) (AP:  3.7mm; ML: ±0.6mm; DV:
 1.85mm). The pipette was held in place for 10min, and then withdrawn slowly.
Twenty-one days later, 0.4 ml of SAD-DG-DsRed (EnvA) (2 108 particles per ml)
was injected into the LP (AP:  2.4mm; ML:±1.5mm; DV:  2.2mm) and 0.2 ml
CTB488 were injected into the DRN.
Similar procedures for injection of CTB were adopted to inject 0.4 ml
AAV-DIO-GCaMP6m, AAV-DIO-eYFP, AAV-DIO-ChR2-mCherry,
AAV-DIO-eNpHR3.0-mCherry and AAV-DIO-mCherry into DRN (virus titres:
4.35 1012 particles per ml, 10 Sert-Cre mice and 11 vGAT-Cre mice were used for
AAV-DIO-GCaMP6m injection; 3 Sert-Cre mice and 3 vGAT-Cre mice were used
for AAV-DIO-eYFP injection; 8 Sert-Cre mice and 7 vGAT-Cre mice were used for
AAV-DIO-ChR2-mCherry injection; 6 vGAT-Cre mice were used for AAV-DIO-
eNpHR3.0- mCherry injection; 10 Sert-Cre mice and 5 vGAT-Cre mice were used
for AAV-DIO-mCherry injection).
Similar procedures for injection of CTB were adopted to inject 0.4 ml
AAV-DIO-hM3D-mCherry or AAV-DIO-hM4D-mCherry into DRN (virus titres:
2.7 1013 particles per ml, 35 Sert-Cre mice were used for AAV-DIO-hM3D-
mCherry injection; 18 vGAT-Cre mice were used for AAV-DIO-hM4D-mCherry
injection).
Following injection, the wound was sutured and antibiotics (bacitracin and
neomycin) were applied to the surgical wound and ketoprofen (5mg kg 1) was
injected subcutaneously; animals were allowed to recover from anaesthesia under a
heat lamp.
Fibre photometry. As described previously43 a ﬁbre photometry system (Thinker
Tech, Nanjing) was used for recording Ca2þ signals from genetically identiﬁed
5-HT and GABA neurons. Brieﬂy, 1 week following AAV-DIO-GCaMP6m virus
injection, an optical ﬁbre (230mm OD, 0.37 numerical aperture (NA); Shanghai
Fiblaser) was placed in a ceramic ferrule and inserted towards the DRN through the
craniotomy (coordinates: AP:  5.2mm; ML: ±0mm; DV:  2.65mm). The
ceramic ferrule was supported with a skull-penetrating M1 screw and dental
acrylic. Mice were individually housed and allowed to recover for at least 1 week.
To record ﬂuorescence signals, the laser beam from a 488-nm laser (OBIS 488LS;
Coherent) was reﬂected by a dichroic mirror (MD498; Thorlabs), focused by a
 10 objective lens (NA¼ 0.3; Olympus) and then coupled to an optical
commutator (Doric Lenses). An optical ﬁbre (230mm OD, NA¼ 0.37, 2-m long)
guided the light between the commutator and the implanted optical ﬁbre. The laser
power was adjusted at the tip of optical ﬁbre to the low level of 0.01–0.02mW,
to minimize bleaching.
The GCaMP6m ﬂuorescence was bandpass ﬁltered (MF525-39, Thorlabs) and
collected by a photomultiplier tube (R3896, Hamamatsu). An ampliﬁer (C7319,
Hamamatsu) was used to convert the photomultiplier tube current output to
voltage signals, which was further ﬁltered through a low-pass ﬁlter (40Hz cut-off;
Brownlee 440). The analogue voltage signals were digitalized at 500Hz and
recorded by a Power 1401 digitizer and Spike2 software (CED, Cambridge, UK).
Injection site veriﬁcation. After transcardial perfusion with 0.9% saline followed
by 4% paraformaldehyde in 0.1M PBS, the brain was removed and post-ﬁxed with
4% paraformaldehyde overnight at 4 C, and then transferred into 30% sucrose
until sectioning with a cryostat (CM1900, Leica Microsystems, Bannockburn,
IL,USA). A series of 40mm sections were collected for veriﬁcation of injection sites;
tissue was examined under epiﬂuorescence using a Leica, DM6000B microscope.
Ablation of DRN-projecting RGCs and melanopsin-expressing RGCs. As
described previously21, C57BL/6 mice received CTB-488 or CTB-647 (for ﬁbre
photometry experiments) (0.2 ml peranimal) deposited in the DRN. Three days
later, mice received bilateral intraocular injection of a custom conjugated
immunotoxin (2mg per eye) (n¼ 10) made between saporin (#IT-27-100,
Advanced Targeting Systems) and an afﬁnity-puriﬁed anti-CTB antibody
(C86204M, Meridian Life Science), or anti-Melanopsin-saproin (n¼ 8) (2 mg per
eye) (#IT-44, Advanced Targeting Systems). Mice (n¼ 10) in the control group
received bilateral intraocular injections of an equal volume 0.1M PBS. After
injection, mice were returned to their home cage for 14 days.
Physiological recording of DRN-projecting RGCs and intracellular injection.
DRN-projecting RGCs were recorded as previously described21,23. Brieﬂy, animals
were anaesthetized (Avertin, 13 ml g 1, i.p.), and eyes were enucleated under dim
red light. The lens and vitreous were carefully removed with a pair of ﬁne-forceps.
The eyecups were ﬂat-mounted, sclera side down, directly on the bottom of a
recording chamber and superfused by oxygenated (95% O2/5% CO2) Ames
medium (Sigma-Aldrich, St Louis, MO, USA) at a ﬁxed rate (5mlmin 1) at room
temperature (22–24 C). Looming stimuli was generated by programming the
Psychophysics Toolbox in Matlab displayed on a Samsung mini LED projector
(Samsung SP-P310ME, Samsung Electronics Co Ltd, Suwon City, Korea) and
imaged with a ﬁrst-surface mirror and lens (Edmond Scientiﬁc, Barrington, NJ,
USA) on the ﬁlm plane of the microscope’s camera port. The luminance level of the
projector was measured with a digital radiometer (S370 Radiometer, UDT
Instruments, San Diego, CA, USA) using a  40 water-immersion objective
(Carl Zeiss, Thornwood, NY, USA). The irradiance was further reduced using
neutral density ﬁlters (Oriel Corp., Stratford, CT, USA). Looming responses of
DRN-projecting RGCs were recorded using a glass microelectrode and ampliﬁed
with a patch clamp ampliﬁer (Multiclamp 700B) and digitized (Digidata 1,440;
Axon Instrument, Inc., Forest City, CA, USA). RGCs retrogradely labelled by CTB
were targeted for recording. Once the physiological proﬁling was completed,
recorded RGCs were intracellularly ﬁlled with neurobiotin for morphological
evaluation. The acquired physiological data were further analysed off-line
(pCLAMP9; Axon Corp., CA, USA).
Physiological recording from brain slices. AAV-DIO-ChR2-mCherry or
AAV-DIO-eNpHR3.0-mCherry virus was injected into the DRN region of
vGAT-Cre or Sert-Cre mice and left for 2–3 weeks. For brain slice preparation,
mice were deeply anaesthetized with pentobarbital (100mg kg 1 i.p.) and coronal
brain slices were cut at 250mm thickness. The slices were recovered for 30min
before recording. Whole-cell patch clamp recordings were made on ChR2-negetive
cell bodies identiﬁed under the ﬂuorescence microscope.
The internal solution within whole-cell recording pipettes (3–5MO) contained
(in mM): 135 KMeSO4, 10 KCl, 10 HEPES, 10 Na2-phosphocreatine, 4 MgATP,
0.3 Na3GTP (pH 7.2–7.4); or CsMeSO4 130, NaCl 10, EGTA 10, MgATP 4,
Na3GTP 0.3, HEPES 10 (pH 7.2–7.4). 0.5% neurobiotin was included in some
recordings for post-recording staining.
Voltage-clamp and current-clamp recordings were performed using a
Multiclamp 700B ampliﬁer (Molecular Devices). For voltage-clamp recordings, the
neurons were held at  60mV. Traces were low-pass ﬁltered at 2 kHz and digitized
at 10 kHz (DigiData 1,550, Molecular Devices). The data were acquired and
analysed using Clampﬁt 10.0 software (Molecular Devices). For light stimulation,
470-nm LED or 590-nm LED (Thorlabs) was used to deliver light pulses (blue light:
4ms  5 pulses at 20Hz; yellow light: 1 s) through digital commands from the
Digidata 1440. The recorded cells were intracellularly ﬁlled with neurobiotin for
morphological evaluation.
Immunocytochemistry. All animals were anaesthetized (Avertin, 13 ml g 1, i.p.)
and perfused intracardially with 0.9% saline followed by 4% paraformaldehyde in
PBS. Brains and eyes were removed.
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For detection of melanopsin, CART and SMI-32 expressing RGCs, retinas were
isolated and washed in 0.1M PBS for three times (10min each) before incubation
in 0.1M PBS containing 10% normal goat serum (Vector Laboratories, Burlingame,
CA, USA) and 0.3% Trition-X-100 (T8787, Sigma-Aldrich, St Louis, MO, USA) for
1 h. Then retinas were incubated for 3 days at 4 C with a rabbit anti-melanopsin
antibody (AB-N38, Advance targeting systems; 1:600) or anti-CART antibody
(H-003-62, Phoenix Pharmaceuticals; 1:1,000) or anti-SMI32 antibody (801703,
Biolegend; 1:1,000). This was followed by six rinses in 0.1M PBS and then
incubation with a secondary (Dylight 488 or Dylight 549) goat-anti-rabbit IgG
(1:400, Vector Laboratories) for 6 h at room temperature.
Retinas with RGCs ﬁlled intracellularly with neurobiotin were ﬁxed for 1 h in
4% paraformaldehyde in 0.1M PBS at room temperature, rinsed in 0.1M PBS for
three times (10min each) and placed in 10% normal goat serum containing 2%
Trition-X-100 for 48 h at 4 C. Retinas were then incubated in Streptavidin-Alexa
Fuor 488 (S32354, Life technologies, 1:100) for 48 h at 4 C. This was followed by
three times rinse in 0.1M PBS. For labelling of cholinergic amacrine cells, retinas
were rinsed in 0.1M PBS for three times (10min time 1) and placed in 10%
normal goat serum containing 2% Trition-X-100 for 1 h at room temperature.
Retinas were then incubated in goat-anti-ChAT antibody (AB144P, Millipore;
1:200) for 48 h at 4 C. This was followed by six times rinse in 0.1M PBS and then
incubation with a secondary antibody Alexa Fluor 594 donkey anti-goat IgG
(1:400, A-11058, Molecular Probes) for 6 h at room temperature. Finally, all retinas
were rinsed in 0.1M PBS and cover-slipped in anti-fading aqueous mounting
medium (EMS, Hatﬁeld, PA, USA).
For c-Fos labelling, 40 mm cryostat sections containing the DRN, SC, LP, BLA
or dorsal periaqueductal grey were placed in blocking solution for 1 h before
incubation in primary antibody against c-Fos (rabbit, 1:500; PC38T, Calbiochem)
(36 h at 4 C). Sections were then incubated with corresponding secondary
antibody at a dilution of 1:400 for 6 h at room temperature: goat anti-rabbit Alexa
488(107909, Jackson ImmunoResearch).
For TPH or GABA labelling, procedures used in c-Fos labelling were adopted
except that the primary antibody was replaced by anti-TPH (mouse, TPH; 1:1,000;
T8575, Sigma-Aldrich) or anti-GABA (mouse, 1:1,000; A0310, Sigma-Aldrich), and
the secondary antibody was replaced by goat anti-mouse Alexa 594 (115-587-003,
Jackson ImmunoResearch) or goat anti-mouse Alexa 647 (115-587-003, Jackson
ImmunoResearch).
Finally, all brain sections were rinsed in 0.1M PBS and cover-slipped in anti-
fading aqueous mounting medium with DAPI (EMS, Hatﬁeld, PA, USA).
Image analysis. Retinas and sections were imaged with a Zeiss 700 confocal
microscope with  5 or  20 objectives, or a  40 oil immersion objective.
For three-dimensional reconstruction of injected or virus labelled RGCs, optical
sections were collected at 0.2 mm intervals. Each stack of optical sections covered a
retinal area of 325.75 325.75mm2 (1,024 1,024 pixels). Using Image J and
Photoshop CS5 (Adobe Corp., San Jose, CA, USA), each stack of optical sections
was montaged and projected to a 0 X–Y plane and a 90 Y–Z plane to obtain a
three-dimensional reconstruction of the cell. Details of three-dimensional recon-
struction and confocal calibration procedures were described elsewhere21. Contrast
and brightness were adjusted and the red-green images had been converted to
magenta-green. Total soma and dendritic ﬁeld size of each ﬁlled cell were analysed.
Dendritic ﬁeld area was calculated by drawing a convex polygon linking the
dendritic terminals. The dendritic ﬁeld area was then calculated and the diameter
expressed as that of a circle having an equal area.
Looming stimulation test. The looming stimulation test was performed in a
50 50 37 cm closed arena with or without a shelter. An LED monitor was
embedded into the ceiling to present the looming stimulus. The looming stimulus,
which consisted of an expanding black disc, appeared at a diameter of 2 to 20
visual angle in 0.25 s, and was presented once in 0.25 s or 15 times in 10.75 s. The
stimulation was triggered by the experimenter manually when mouse was in the
centre of the arena.
For ﬁbre photometry recording of Ca2þ signals from genetically identiﬁed
DRN 5-HT and GABA neurons, an implanted optic ﬁbre was connected to the
ﬁbre photometry system, and the Ca2þ signals were recorded during the whole test
session (looming stimulus was presented 15 times per trial).
For the chemico-genetic experiments, Sert-Cre or vGAT-Cre mice were
intraperitoneally treated with either saline or Clozapine N-oxide (CNO, 2mg kg 1,
ab141704, abcam) 30min before testing in an arena with or without a shelter
(Looming stimulus was presented 15 times per trial).
For the optogenetic activation experiment, an implanted ﬁbre optic was
connected to a 463-nm blue light laser or 590-nm yellow light laser and the light
power was set to about 10mW at the ﬁbre tip. The duration of neuronal activation
fully encompassed the duration of the looming stimulus.
Optomotor test. Optomotor responses of animals in VEH (n¼ 6 animals) and
anti-CTB-SAP (n¼ 6 animals) groups were measured as described by Abdeljalil
et al.52. Brieﬂy, mice were placed on a platform in the form of a grid (12 cm
diameter, 19.0 cm above the bottom of the drum) surrounded by a motorized drum
(29.0 cm diameter) that could be revolved clock-wise or anticlockwise at two
revolutions per minute. After 10min of adaptation in the dark, vertical black and
white stripes of a deﬁned spatial frequency were presented to the animal. These
stripes were rotated alternately clockwise and anticlockwise, for 2min in each
direction with an interval of 30 s between the two rotations. Various spatial
frequencies subtending 0.03, 0.13, 0.26, 0.52 and 1.25 cycles degree 1 were tested
individually on different days in a random sequence. Animals were videotaped with
an infrared digital video camera for subsequent scoring of head tracking
movements. Procedures for measuring optomotor responses under photopic
condition were similar to the scotopic condition except that animals were subjected
to 400 Lux during 5min to allow them to adapt to the light.
Statistics. Data analysis was done by experimenters blind to experimental
conditions. One-way ANOVA were used to quantify duration from start to end,
peak speed during and after looming stimulation, number of c-Fosþ cells, and
ipRGCs. Data are shown as mean±s.e. of the mean (s.e.m.). Statistical signiﬁcance
was set at Po0.05.
Multivariate permutation test was used to analyse the statistical signiﬁcance of
the event-related ﬂuorescence change (ERF). One thousand permutations for an
a-level of 0.05 were used to compare the values of DF/F at each time point with the
ERF baseline values. A series of statistical P value at each time point were generated
and the statistical results were superimposed on the average ERF curve with red
and blue lines indicating statistically signiﬁcant (Po0.05) increase or decrease,
respectively.
To calculate the amplitude and activation duration of DF/F values, we ﬁrst
segmented the data based on the behavioural events of with/without looming
stimulation. The 95% fraction of the baseline DF/F values deﬁned as the
up-threshold value and the 5% fraction as the low threshold. We then detected the
local signal peaks during a given interaction bout using the MATLAB ﬁndpeaks
function. The response amplitude of a behavioural bout was calculated by
averaging all the local peaks above the up-threshold value. The activation duration
and inhibition duration was calculated by summing the time points above the up
threshold or below the low threshold, respectively. The average bout peaks,
activation duration and inhibition duration were averaged across the behavioural
session to report the corresponding values of a given mouse.
Data availability. Data from the experiments presented in the current study are
available from the corresponding authors on reasonable request.
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